NUTRA PHARMA CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | 0.00% |
|
0.00% | +9,900.00% |
| 03-22 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
| 03-22 | Nutra Pharma Corporation Announces Management Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 710K | - | - | - | - | - | |
| 53.67B | - | |||||
| 38.86B | ||||||
| 38.76B | ||||||
| 27.27B | ||||||
| 25.91B |
- Stock Market
- Equities
- NPHC Stock
- Charts Nutra Pharma Corp.
- Sector Chart